Filing Details
- Accession Number:
- 0001553878-18-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-14 19:39:43
- Reporting Period:
- 2018-03-13
- Accepted Time:
- 2018-03-14 19:39:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236447 | Paul Schimmel | 300 Third Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-13 | 10,000 | $30.09 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-03-13 | 2,823 | $63.86 | 12,823 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-03-13 | 15,000 | $59.25 | 27,823 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-13 | 27,823 | $150.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-13 | 15,000 | $0.00 | 15,000 | $59.25 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-13 | 2,823 | $0.00 | 2,823 | $63.86 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-13 | 10,000 | $0.00 | 10,000 | $30.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-06-05 | 2024-06-04 | No | 4 | M | Direct |
| 0 | 2014-03-31 | 2024-01-02 | No | 4 | M | Direct |
| 0 | 2014-06-06 | 2023-06-06 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 306,996 | Indirect | by Trust |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2017.
- The Paul Schimmel Prototype PSP has holdings of 188,601 shares and the reporting person is trustee. The Schimmel Revocable Trust U/A dated 9/6/2000 has holdings of 118,395 shares and the reporting person and his spouse are trustees.
- The stock option vests as to 25% on 3/31/2014 and as to an additional 25% of the shares granted at the end of each subsequent quarter.
Billionaire Hedge Funds
